perioperative management of glp 1 agonists Impact GLP-1 Receptor in Gastrointestinal Endoscopy: An Updated Review GLP-1 receptor agonists like semaglutide

Medical community engagement through professional societies supports standardization of treatment protocols and prescribing practices

During recovery phase Continue all supportive measures until regrowth is well established

The Trump administration announced initiatives in November 2025 to expand GLP-1 access for Medicare beneficiaries with obesity plus significant comorbidities, with implementation expected around mid-2026

CMS initially stated that for future model years, the agency was considering additional payment incentives, including higher direct subsidy payments based on an adjustment factor to the beneficiary risk score in participating plan bids

North America led the market in 2024 with over 50.14% share, generating around USD 5.4 Billion in revenue

Evidence also suggests antidepressant effects of GLP-1RAs